Mizar Therapeutics is a platform therapeutics company using proprietary live-cell, single-molecule imaging and machine-learning technology for discovery of a new class of targeted cancer therapies.
Our platform consists of two intertwined elements: live-cell super-resolution imaging and AI-powered data extraction.
Our goal: to identify effective condensate modulators to novel targeted cancer therapeutics.
Condensates compartmentalizing proteins and nucleic acids are often the location of dysregulation in cancer, and the pharmacodynamics of cancer therapeutics can be affected by condensates.
We deploy our live-cell super-resolution technology to determine the interaction of lead compounds and condensate components in intact cells.
Our imaging at high frequency and over extended durations gives us unparalleled input data for our machine learning algorithms, meaning novel insight into hit discovery, hit-to-lead, target identification, mode of action and lead optimization.
Company Details
- Employees
- 3
- Address
- 7 M B L St,
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://mizartx.com/
- Keywords
- Woods Hole.
- HQ
- Woods Hole, Massachusetts
Mizar Therapeutics Questions
Mizar Therapeutics's website is https://mizartx.com/
Mizar Therapeutics's LinkedIn profile is https://www.linkedin.com/company/mizar-therapeutics
Mizar Therapeutics has
3 employees.
View email and phone details for 3
employees at Mizar Therapeutics.
Mizar Therapeutics's industry is
Biotechnology Research
Mizar Therapeutics's top competitors are
Mizar Imaging,
Heads Together Health,
Innovation Management,
Samsara Therapeutics,
Constant Therapy,
Quantworks, Inc.,
Delaqua Pharmaceuticals,
Flo Materials,
Truspin Nanomaterial Innovation, Inc.,
Primeneuro.
Mizar Therapeutics's categories are Biotechnology Research
